Related Experiment Video

Updated: Jul 5, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Epigenetic dysregulation in thyroid neoplasia

Tetsuo Kondo1, Sylvia L Asa, Shereen Ezzat

  • 1Department of Pathology, University of Yamanashi, Japan.

Endocrinology and Metabolism Clinics of North America
|May 27, 2008
PubMed

Insights

Epigenetic gene silencing plays a crucial role in thyroid cancer development. Understanding these epigenetic changes offers new avenues for thyroid cancer diagnosis and targeted therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Thyroid carcinogenesis involves oncogene mutations and tumor suppressor gene inactivation.
  • Epigenetic events are increasingly recognized for their role in human tumorigenesis.
  • Epigenetic silencing of tumor suppressor and thyroid hormone-related genes occurs in thyroid tumors.

Purpose of the Study:

  • To review evidence of epigenetic gene dysregulation in follicular cell-derived thyroid carcinomas.
  • To discuss the role of epigenetics in the development and progression of thyroid cancer.
  • To explore future applications of epigenetics in thyroid cancer diagnostics and therapeutics.

Main Methods:

  • Literature review of studies on epigenetic gene dysregulation in thyroid cancer.
  • Analysis of evidence for epigenetic silencing in papillary, follicular, and undifferentiated thyroid carcinomas.
  • Synthesis of current understanding of epigenetic mechanisms in thyroid tumorigenesis.

Main Results:

  • Epigenetic gene dysregulation is evident across various thyroid carcinoma subtypes.
  • Specific tumor suppressor and thyroid hormone-related genes are frequently epigenetically silenced.
  • These epigenetic alterations contribute to thyroid cancer development and progression.

Conclusions:

  • Epigenetic modifications are significant drivers in follicular cell-derived thyroid carcinomas.
  • Epigenetics holds promise for developing novel diagnostic tools for thyroid cancer.
  • Targeted epigenetic therapies represent a future direction for thyroid cancer treatment.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...